Voting Rights Announcements | 16 December 2015 18:31

Elanix Biotechnologies AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

DGAP Voting Rights Announcement: Elanix Biotechnologies AG

2015-12-16 / 18:31
Dissemination of a Voting Rights Announcement transmitted by DGAP – a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Notification of Major Holdings

1. Details of issuer

Elanix Biotechnologies AG
Fritz-Vomfelde-Straße 34
40547 Düsseldorf
Germany

2. Reason for notification

X	Acquisition/disposal of shares with voting rights
	Acquisition/disposal of instruments
X	Change of breakdown of voting rights
	Other reason:

3. Details of person subject to the notification obligation

Name:	City and country of registered office:
Mr Prof. Wassim Raffoul

4. Names of shareholder(s)
holding directly 3% or more voting rights, if different from 3.

Lee-Ann Laurent-Applegate, Corinne Scaletta, Tomas Svoboda

5. Date on which threshold was crossed or reached

09.12.2015

6. Total positions

	% of voting rights attached to shares (total of 7.a.)	% of voting rights through instruments (total of 7.b.1 + 7.b.2)	total of both in % (7.a. + 7.b.)	total number of voting rights of issuer
Resulting situation	65,25 %	0 %	65,25 %	5166000
Previous notification	42,59 %	0 %	42,59 %	/

7. Notified details of the resulting situation
a. Voting rights attached to shares (Sec.s 21, 22 WpHG)

ISIN	absolute		in %
	direct (Sec. 21 WpHG)	indirect (Sec. 22 WpHG)	direct (Sec. 21 WpHG)	indirect (Sec. 22 WpHG)
DE000A0WMJQ4	172028	3198787	3,33 %	61,92 %
Total	3370815		65,25 %

b.1. Instruments according to Sec. 25 Abs. 1 Nr. 1 WpHG

Type of instrument	Expiration or maturity date	Exercise or conversion period	Voting rights absolute	Voting rights in %
		Total		%

b.2. Instruments according to Sec. 25 Abs. 1 Nr. 2 WpHG

Type of instrument	Expiration or maturity date	Exercise or conversion period	Cash or physical settlement	Voting rights absolute	Voting rights in %
			Total		%

8. Information in relation to the person subject to the notification obligation

X	Person subject to the notification obligation is not controlled and does itself not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer (1.).
	Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity:

Name % of voting rights (if at least held 3% or more) % of voting rights through instruments (if at least held 5% or more) Total of both (if at least held 5% or more)

9. In case of proxy voting according to § 22 Abs. 3 WpHG

Date of general meeting:
Holding position after general meeting:	% (equals voting rights)

2015-12-16 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

Language:	English
Company:	Elanix Biotechnologies AG
	Fritz-Vomfelde-Straße 34
	40547 Düsseldorf
	Germany

End of News DGAP News Service